The metabolic score for insulin resistance index is associated with myocardial ischemia, with non-alcoholic fatty liver disease serving as an important bridge

胰岛素抵抗指数的代谢评分与心肌缺血相关,而非酒精性脂肪肝疾病则扮演着重要的桥梁角色。

阅读:1

Abstract

BACKGROUND: This study aimed to evaluate the correlation between the metabolic score for insulin resistance (METS-IR) and myocardial ischemia based on myocardial perfusion imaging (MPI) and further examine whether non-alcoholic fatty liver disease (NAFLD) has a potential role in mediating these associations. METHODS: This retrospective study enrolled 1,242 patients with suspected coronary artery disease (CAD) who underwent single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) at the Third Affiliated Hospital of Soochow University from 1 January 2022 to 31 December 2024. The association between METS-IR and myocardial ischemia was analyzed using the logistic regression model. The mediating effect of NAFLD was evaluated through mediation analysis to explore the potential mechanism underlying the association between METS-IR and myocardial ischemia. RESULTS: The final group of participants included 335 patients; 179 (53.4%) patients had myocardial ischemia. Overall, the mean age was 61.45 ± 10.20 years, 188 (56.1%) were men, and the mean body mass index was 24.69 ± 3.21 kg/m(2). Mean METS-IR was 2.40 ± 0.22 (range, 1.79-3.80). The results of the single-factor analysis showed that a per-SD increase in METS-IR was independently associated with myocardial ischemia (OR, 3.92; 95% CI: 1.38-11.08; P =0.010). After adjusting for all interfering factors, METS-IR had no associations with myocardial ischemia. The results of the mediation analysis show that NAFLD is a complete mediator variable between MERSIR and myocardial ischemia. CONCLUSION: This study provides evidence for the relationship between METS-IR and myocardial ischemia and highlights the important mediating role of NAFLD in this relationship.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。